Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

RSS icon
Thumbnail

Same-day discharge for AFib ablation a success thanks to telehealth

The new analysis, presented during Heart Rhythm 2022, focused on patients treated at a high-volume facility during the COVID-19 pandemic. 

VIDEO: How to implant a Linq implantable cardiac monitor

The Medtronic Linq and Linq II implantable cardiac monitors (ICM) have become some of the most popular ICM devices on the market, partly because they are easy to insert.

Same-day discharge after LAAO associated with strong outcomes, significant cost savings

A new analysis found that 30-day outcomes do not significantly change when LAAO patients go home the same day as their procedure. 

Fitbit’s latest AFib algorithm receives FDA clearance, will be available ‘soon’

The new algorithm was designed to evaluate a user's heart rhythm while they are still or even sleeping. 

An implantable cardioverter defibrillator (ICD) and its associated leads viewed on a X-ray. Old leads are often abandon in veins and new ones added, but a new study of 1 million patients at ACC22 showed there is higher mortality if a device becomes infected and the leads are left behind. Image from RSNA.

VIDEO: Lowering mortality rates from infected EP implantable cardiac devices

Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.

Smartwatch app accurately detects atrial fibrillation in large Chinese study

A Chinese study of 2.8 million participants found that 94% of users flagged for AFib indeed have the heart rhythm disorder.

Abbott’s Aveir single-chamber (VR) leadless pacemaker

Abbott’s single-chamber leadless pacemaker gains FDA approval

Another single-chamber leadless pacemaker has officially hit the market. 

Thumbnail

DOACs may reduce the risk of dementia among AFib patients by 50%

Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis. 

Displaying 257 - 264 of 311
Design by Adaptive Theme